6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: Sofgen Pharma S.A.
Filed: September 7, 2023
Period of Report: September 7, 2023
Accession Number: 0001213900-23-074569

View Document ↗ View on SEC.gov ↗